171 related articles for article (PubMed ID: 15482914)
1. Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
Becker DP; Flynn DL; Shone RL; Gullikson G
Bioorg Med Chem Lett; 2004 Nov; 14(22):5509-12. PubMed ID: 15482914
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological properties of benzamide derivatives as selective serotonin 4 receptor agonists.
Sonda S; Katayama K; Kawahara T; Sato N; Asano K
Bioorg Med Chem; 2004 May; 12(10):2737-47. PubMed ID: 15110855
[TBL] [Abstract][Full Text] [Related]
3. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
[TBL] [Abstract][Full Text] [Related]
4. Bridgehead-methyl analog of SC-53116 as a 5-HT4 agonist.
Becker DP; Flynn DL; Villamil CI
Bioorg Med Chem Lett; 2004 Jun; 14(12):3073-5. PubMed ID: 15149647
[TBL] [Abstract][Full Text] [Related]
5. 5-HT4 receptor agonists: similar but not the same.
De Maeyer JH; Lefebvre RA; Schuurkes JA
Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
[TBL] [Abstract][Full Text] [Related]
6. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists.
Becker DP; Flynn DL; Moormann AE; Nosal R; Villamil CI; Loeffler R; Gullikson GW; Moummi C; Yang DC
J Med Chem; 2006 Feb; 49(3):1125-39. PubMed ID: 16451077
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of benzamide derivatives as selective 5-HT(4) receptor agonists.
Sonda S; Kawahara T; Katayama K; Sato N; Asano K
Bioorg Med Chem; 2005 May; 13(9):3295-308. PubMed ID: 15809165
[TBL] [Abstract][Full Text] [Related]
10. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
Manabe N; Wong BS; Camilleri M
Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
[TBL] [Abstract][Full Text] [Related]
11. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs.
Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810
[TBL] [Abstract][Full Text] [Related]
12. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.
Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M
Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
Yoshida N; Omoya H; Kato S; Ito T
Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses.
Delco ML; Nieto JE; Craigmill AL; Stanley SD; Snyder JR
Vet Ther; 2007; 8(1):77-87. PubMed ID: 17447227
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
[TBL] [Abstract][Full Text] [Related]
17. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the pharmacology of gastrointestinal prokinetics.
Tonini M
Pharmacol Res; 1996; 33(4-5):217-26. PubMed ID: 8938012
[TBL] [Abstract][Full Text] [Related]
19. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
[TBL] [Abstract][Full Text] [Related]
20. A 5-HT(4)-receptor activation-induced neural plasticity enhances in vivo reconstructs of enteric nerve circuit insult.
Matsuyoshi H; Kuniyasu H; Okumura M; Misawa H; Katsui R; Zhang GX; Obata K; Takaki M
Neurogastroenterol Motil; 2010 Jul; 22(7):806-13, e226. PubMed ID: 20146727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
